The GC–MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology | SpringerLink https://t.co/gh7IkkoLZX
Fascinating... The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. - PubMed - NCBI https://t.co/KiChfVzvEZ
RT @gavin_barlow: The GC–MS #metabolomics signature in patients with #fibromyalgia syndrome directs to #dysbiosis as an aspect contributing…
The GC–MS #metabolomics signature in patients with #fibromyalgia syndrome directs to #dysbiosis as an aspect contributing factor of FMS pathophysiology (So wonder if that gut #microbiota-urinary signal can be exploited for other things?). https://t.co/zmXy
They are making some strong claims, worth exploring perhaps.
The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. Metabolomics #metabolomics https://t.co/h4a7ElZFlo
The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. https://t.co/v9H1DsGPgZ
The GC–MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology #Metabolomics https://t.co/60A6xU9C42